199 related articles for article (PubMed ID: 35135710)
1. Breast and axillary surgery after neoadjuvant systemic treatment - A review of clinical routine recommendations and the latest clinical research.
Pfob A; Heil J
Breast; 2022 Mar; 62 Suppl 1(Suppl 1):S7-S11. PubMed ID: 35135710
[TBL] [Abstract][Full Text] [Related]
2. Breast surgery after neoadjuvant therapy.
Gnant M
Curr Opin Oncol; 2022 Nov; 34(6):643-646. PubMed ID: 36083127
[TBL] [Abstract][Full Text] [Related]
3. Targeted axillary dissection and sentinel lymph node biopsy in breast cancer patients after neoadjuvant chemotherapy - a retrospective study.
Coufal O; Zapletal O; Gabrielová L; Fabian P; Schneiderová M
Rozhl Chir; 2018; 97(12):551-557. PubMed ID: 30646734
[TBL] [Abstract][Full Text] [Related]
4. Sentinel lymph node biopsy performed after neoadjuvant chemotherapy is accurate in patients with documented node-positive breast cancer at presentation.
Newman EA; Sabel MS; Nees AV; Schott A; Diehl KM; Cimmino VM; Chang AE; Kleer C; Hayes DF; Newman LA
Ann Surg Oncol; 2007 Oct; 14(10):2946-52. PubMed ID: 17514407
[TBL] [Abstract][Full Text] [Related]
5. Sentinel node biopsy before neoadjuvant chemotherapy for determining axillary status and treatment prognosis in locally advanced breast cancer.
Cox CE; Cox JM; White LB; Stowell NG; Clark JD; Allred N; Meyers M; Dupont E; Furman B; Minton S
Ann Surg Oncol; 2006 Apr; 13(4):483-90. PubMed ID: 16523361
[TBL] [Abstract][Full Text] [Related]
6. Sentinel node biopsy before neoadjuvant chemotherapy spares breast cancer patients axillary lymph node dissection.
van Rijk MC; Nieweg OE; Rutgers EJ; Oldenburg HS; Olmos RV; Hoefnagel CA; Kroon BB
Ann Surg Oncol; 2006 Apr; 13(4):475-9. PubMed ID: 16485148
[TBL] [Abstract][Full Text] [Related]
7. Outcome following sentinel lymph node biopsy-guided decisions in breast cancer patients with conversion from positive to negative axillary lymph nodes after neoadjuvant chemotherapy.
Kang YJ; Han W; Park S; You JY; Yi HW; Park S; Nam S; Kim JH; Yun KW; Kim HJ; Ahn SH; Park S; Lee JE; Lee ES; Noh DY; Lee JW
Breast Cancer Res Treat; 2017 Nov; 166(2):473-480. PubMed ID: 28766131
[TBL] [Abstract][Full Text] [Related]
8. The problem of axillary staging in breast cancer after neoadjuvant chemotherapy. Role of targeted axillary dissection and types of lymph node markers.
Flores-Funes D; Aguilar-Jiménez J; Martínez-Gálvez M; Ibáñez-Ibáñez MJ; Carrasco-González L; Gil-Izquierdo JI; Aguayo-Albasini JL
Cir Esp (Engl Ed); 2020 Nov; 98(9):510-515. PubMed ID: 32386728
[TBL] [Abstract][Full Text] [Related]
9. Would Removal of All Ultrasound Abnormal Metastatic Lymph Nodes Without Sentinel Lymph Node Biopsy Be Accurate in Patients with Breast Cancer with Neoadjuvant Chemotherapy?
Lim GH; Gudi M; Teo SY; Ng RP; Yan Z; Lee YS; Allen JC; Leong LCH
Oncologist; 2020 Nov; 25(11):e1621-e1627. PubMed ID: 32537791
[TBL] [Abstract][Full Text] [Related]
10. Axillary management for patients with breast cancer after neoadjuvant chemotherapy: Results of a survey among Brazilian breast surgeons.
Frasson AL; Resende HM; Lichtenfels M; Barbosa F; de Souza ABA; Miranda I; Falcone AB
J Surg Oncol; 2020 Nov; 122(6):1247-1251. PubMed ID: 33045117
[TBL] [Abstract][Full Text] [Related]
11. Axillary staging prior to neoadjuvant chemotherapy: the roles of sentinel lymph node biopsy and axillary ultrasonography.
Lee MC; Joh JE; Chau A
Cancer Control; 2012 Oct; 19(4):277-85. PubMed ID: 23037495
[TBL] [Abstract][Full Text] [Related]
12. Surgical management of early stage invasive breast cancer: a practice guideline.
McCready D; Holloway C; Shelley W; Down N; Robinson P; Sinclair S; Mirsky D; ;
Can J Surg; 2005 Jun; 48(3):185-94. PubMed ID: 16013621
[TBL] [Abstract][Full Text] [Related]
13. False-negative rate in the extended prospective TATTOO trial evaluating targeted axillary dissection by carbon tattooing in clinically node-positive breast cancer patients receiving neoadjuvant systemic therapy.
de Boniface J; Frisell J; Kühn T; Wiklander-Bråkenhielm I; Dembrower K; Nyman P; Zouzos A; Gerber B; Reimer T; Hartmann S
Breast Cancer Res Treat; 2022 Jun; 193(3):589-595. PubMed ID: 35451733
[TBL] [Abstract][Full Text] [Related]
14. Is it always necessary to perform an axillary lymph node dissection after neoadjuvant chemotherapy for breast cancer?
Osorio-Silla I; Gómez Valdazo A; Sánchez Méndez JI; York E; Díaz-Almirón M; Gómez Ramírez J; Rivas Fidalgo S; Oliver JM; Álvarez CM; Hardisson D; Díaz Miguel M; Lobo F; Díaz Domínguez J
Ann R Coll Surg Engl; 2019 Mar; 101(3):186-192. PubMed ID: 30421628
[TBL] [Abstract][Full Text] [Related]
15. Axillary sentinel lymph node biopsy after neoadjuvant chemotherapy for carcinoma of the breast.
Schwartz GF; Tannebaum JE; Jernigan AM; Palazzo JP
Cancer; 2010 Mar; 116(5):1243-51. PubMed ID: 20087958
[TBL] [Abstract][Full Text] [Related]
16. Role of gamma probe-assisted intraoperative sentinel lymph node evaluation in predicting axillary breast cancer metastasis after neoadjuvant chemotherapy.
Berberoglu K; Erdemir A; Rasa K; Baloglu H; Cakmakci M
Nucl Med Commun; 2020 Feb; 41(2):120-125. PubMed ID: 31764597
[TBL] [Abstract][Full Text] [Related]
17. Intelligent Vacuum-Assisted Biopsy to Identify Breast Cancer Patients With Pathologic Complete Response (ypT0 and ypN0) After Neoadjuvant Systemic Treatment for Omission of Breast and Axillary Surgery.
Pfob A; Sidey-Gibbons C; Rauch G; Thomas B; Schaefgen B; Kuemmel S; Reimer T; Hahn M; Thill M; Blohmer JU; Hackmann J; Malter W; Bekes I; Friedrichs K; Wojcinski S; Joos S; Paepke S; Degenhardt T; Rom J; Rody A; van Mackelenbergh M; Banys-Paluchowski M; Große R; Reinisch M; Karsten M; Golatta M; Heil J
J Clin Oncol; 2022 Jun; 40(17):1903-1915. PubMed ID: 35108029
[TBL] [Abstract][Full Text] [Related]
18. Sentinel lymph node mapping following neoadjuvant chemotherapy for breast cancer.
Brady EW
Breast J; 2002; 8(2):97-100. PubMed ID: 11896755
[TBL] [Abstract][Full Text] [Related]
19. Targeted axillary dissection with preoperative tattooing of biopsied positive axillary lymph nodes in breast cancer.
Gatek J; Petru V; Kosac P; Ratajsky M; Duben J; Dudesek B; Jancik P; Zabojnikova M; Katrusak J; Opelova P; Podrazska L; Vazan P; Kudlova P; Holik P; Melichar B; Vrana D
Neoplasma; 2020 Nov; 67(6):1329-1334. PubMed ID: 32749847
[TBL] [Abstract][Full Text] [Related]
20. Axillary dissection in sentinel lymph node positive breast cancer: Is the staging information worthwhile for patients?
Chang DW; Bressel M; Hansen C; Blinman P; Schofield P; Chua BH
Asia Pac J Clin Oncol; 2021 Apr; 17(2):e27-e34. PubMed ID: 31461222
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
